Epigenetics and cardiovascular disease.
Epigenetics and cardiovascular disease.
复制标题
DOI:
10.1038/nrcardio.2010.104
复制
发表时间:
2010-09
影响因子:
49.6
通讯作者:
Smith, Caren E.
中科院分区:
文献类型:
--
作者:
Ordovas, Jose M.;Smith, Caren E.
Despite advances in the prevention and management of cardiovascular disease (CVD), this group of multifactorial disorders remains a leading cause of mortality worldwide. CVD is associated with multiple genetic and modifiable risk factors; however, known environmental and genetic influences can only explain a small part of the variability in CVD risk, which is a major obstacle for its prevention and treatment. A more thorough understanding of the factors that contribute to CVD is, therefore, needed to develop more efficacious and cost-effective therapy. Application of the ‘omics’ technologies will hopefully make these advances a reality. Epigenomics has emerged as one of the most promising areas that will address some of the gaps in our current knowledge of the interaction between nature and nurture in the development of CVD. Epigenetic mechanisms include DNA methylation, histone modification, and microRNA alterations, which collectively enable the cell to respond quickly to environmental changes. A number of CVD risk factors, such as nutrition, smoking, pollution, stress, and the circadian rhythm, have been associated with modification of epigenetic marks. Further examination of these mechanisms may lead to earlier prevention and novel therapy for CVD.
登录
查看更多内容
影响因子:
4.8
作者:
Balasubramanyam, K;Varier, RA;Kundu, TK
通讯作者:
Kundu, TK
影响因子:
5.3
作者:
Buysschaert I;Schmidt T;Roncal C;Carmeliet P;Lambrechts D
通讯作者:
Lambrechts D
影响因子:
2.9
作者:
Chen, ZX;Riggs, AD
通讯作者:
Riggs, AD
DOI:
10.1164/rccm.200807-1097oc
发表时间:
2009-04-01
影响因子:
24.7
作者:
Baccarelli, Andrea;Wright, Robert O.;Schwartz, Joel
通讯作者:
Schwartz, Joel
影响因子:
4.2
作者:
Fang, Mingzhu;Chen, Dapeng;Yang, Chung S.
通讯作者:
Yang, Chung S.